During the past decade, Centro de Investigacion en Artritis y Osteoporosis conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Investigacion en Artritis y Osteoporosis" are "Lupus Erythematosus, Systemic" (2 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Centro de Investigacion en Artritis y Osteoporosis" in a lesser frequency.

Most popular intervention types in "Centro de Investigacion en Artritis y Osteoporosis" are "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CC-220" (1 trials), "Daxdilimab" (1 trials) and "VIB7734" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigacion en Artritis y Osteoporosis" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigacion en Artritis y Osteoporosis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Centro de Investigacion en Artritis y Osteoporosis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigacion en Artritis y Osteoporosis, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".